QinetiQ remains on track for year

Defence firm QinetiQ said it remains on course to achieve expectations for the financial year ending March 31st 2013 after a robust UK services performance and as challenging US market conditions persist.

Defence firm QinetiQ said it remains on course to achieve expectations for the financial year ending March 31st 2013 after a robust UK services performance and as challenging US market conditions persist.

The group, which last month secured a £1bn deal with the Ministry of Defence to support to the armed forces over the next five years, said UK Services continues to perform well.

The division is "benefiting from a more competitive cost base, better project execution and improved alignment with customer needs and it is also continuing to explore the medium-term opportunities presented by MOD's defence transformation programme," QinetiQ said in a statement.

However it cautioned that in the US, market conditions remain challenging with order flow and visibility much lower than usual as customers defer decisions due to continued budget uncertainty.

QinetiQ said the business is proactively managing its cost base in order to maintain competitive rates.

"These actions are focused on cutting property and infrastructure costs, as well as reducing management layers, and will result in an exceptional charge this financial year of approximately $25m," it said.

Meanwhile QinetiQ reiterated that the performance of Global Products for the year will be first half weighted following the delivery of key orders for Q-Nets and spares during the first six months of the year

Last week QinetiQ confirmed its OptaSense distributed acoustic sensing (DAS) business has signed follow-on contracts with Shell.

The group said its balance sheet and cash generation remain strong.

CJ

Recommended

Imperial Brands has an 8.3% yield – but what’s the catch?
Share tips

Imperial Brands has an 8.3% yield – but what’s the catch?

Tobacco company Imperial Brands boasts an impressive dividend yield, and the shares look cheap. But investors should beware, says Rupert Hargreaves. H…
20 May 2022
Investing in drugmakers: uncommon profits from curing rare diseases
Share tips

Investing in drugmakers: uncommon profits from curing rare diseases

Treatments for medical conditions with only a small number of sufferers can still be very attractive for pharmaceutical companies and investors becaus…
20 May 2022
Share tips of the week – 20 May
Share tips

Share tips of the week – 20 May

MoneyWeek’s comprehensive guide to the best of this week’s share tips from the rest of the UK's financial pages.
20 May 2022
Delivering profits: should you buy Royal Mail shares?
Share tips

Delivering profits: should you buy Royal Mail shares?

The volume of parcels delivered by Royal Mail soared during the pandemic, and so did its profits. But it has been coming under pressure lately. So, as…
19 May 2022

Most Popular

Barry Norris: we’re already in the 1970s. Here’s how to invest
Investment strategy

Barry Norris: we’re already in the 1970s. Here’s how to invest

Merryn talks to Barry Norris of Argonaut capital about the parallels between now and the 1970s; the transition to “green” energy; and the one sector w…
19 May 2022
The ten highest dividend yields in the FTSE 100
Income investing

The ten highest dividend yields in the FTSE 100

Rupert Hargreaves looks at the FTSE 100’s top yielding stocks for income investors to consider.
18 May 2022
Share tips of the week – 20 May
Share tips

Share tips of the week – 20 May

MoneyWeek’s comprehensive guide to the best of this week’s share tips from the rest of the UK's financial pages.
20 May 2022